{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T09:56:07Z","timestamp":1781862967014,"version":"3.54.5"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDRIG\/I5\/2024-01-00541"],"award-info":[{"award-number":["EMDRIG\/I5\/2024-01-00541"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDRIG\/I5\/2024-01-00541"],"award-info":[{"award-number":["EMDRIG\/I5\/2024-01-00541"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDRIG\/I5\/2024-01-00541"],"award-info":[{"award-number":["EMDRIG\/I5\/2024-01-00541"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDRIG\/I5\/2024-01-00541"],"award-info":[{"award-number":["EMDRIG\/I5\/2024-01-00541"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDRIG\/I5\/2024-01-00541"],"award-info":[{"award-number":["EMDRIG\/I5\/2024-01-00541"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDRIG\/I5\/2024-01-00541"],"award-info":[{"award-number":["EMDRIG\/I5\/2024-01-00541"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDRIG\/I5\/2024-01-00541"],"award-info":[{"award-number":["EMDRIG\/I5\/2024-01-00541"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"DOI":"10.1007\/s11912-026-01805-3","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T09:37:04Z","timestamp":1781861824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clusterin in Head and Neck Squamous Cell Carcinoma: Diagnostic, Prognostic, and Therapeutic Implications"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8931-0598","authenticated-orcid":false,"given":"Ashmita","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1486-8125","authenticated-orcid":false,"given":"Vinay","family":"Bisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9825-1026","authenticated-orcid":false,"given":"Yogita","family":"Dhurandhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9399-8337","authenticated-orcid":false,"given":"Surendra H.","family":"Bodakhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6091-5315","authenticated-orcid":false,"given":"Ashok K.","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0759-4174","authenticated-orcid":false,"given":"Gauri","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1319-0486","authenticated-orcid":false,"given":"Kamta P.","family":"Namdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"1805_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0330805","volume":"20","author":"M Deng","year":"2025","unstructured":"Deng M, Lin Y, Yan L, Fei Z, Chen C, Ding J. Global burden of head and neck cancer from 1990 to 2021: a comprehensive analysis and projections to 2030 based on the global burden of disease study 2021. PLoS One. 2025;20:e0330805. https:\/\/doi.org\/10.1371\/journal.pone.0330805.","journal-title":"PLoS One"},{"key":"1805_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.wjorl.2016.05.004","volume":"2","author":"EA Mroz","year":"2016","unstructured":"Mroz EA, Rocco JW. High risk cutaneous squamous cell carcinoma of the head and neck. World J Otorhinolaryngol Head Neck Surg. 2016;2:60\u20137. https:\/\/doi.org\/10.1016\/j.wjorl.2016.05.004.","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"1805_CR3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42381","volume":"15","author":"AA Hashmi","year":"2023","unstructured":"Hashmi AA, Bukhari U, Aslam M, Joiya RS, Kumar R, Malik UA, et al. Buried penis: a rare cause of lower urinary tract symptoms in the pediatric population. Cureus. 2023;15:e42381. https:\/\/doi.org\/10.7759\/cureus.42381.","journal-title":"Cureus"},{"key":"1805_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/jcrt.JCRT20120","volume":"20","author":"S Gupta","year":"2024","unstructured":"Gupta S, Pandey P, Verma S, Verma A. P16, p53 and EGFR expression in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters. J Cancer Res Ther. 2024;20:61\u20137. https:\/\/doi.org\/10.4103\/jcrt.JCRT20120.","journal-title":"J Cancer Res Ther"},{"key":"1805_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/ijms.87927","volume":"22","author":"X Du","year":"2025","unstructured":"Du X, Chen Z, Shui W. Clusterin: structure, function and roles in disease. Int J Med Sci. 2025;22:1\u201315. https:\/\/doi.org\/10.7150\/ijms.87927.","journal-title":"Int J Med Sci"},{"key":"1805_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2147\/OTT.S58622","volume":"7","author":"T Koltai","year":"2014","unstructured":"Koltai T. Clusterin: a key player in cancer chemoresistance and its inhibition. OncoTargets Ther. 2014;7:447\u201356. https:\/\/doi.org\/10.2147\/OTT.S58622.","journal-title":"OncoTargets Ther"},{"key":"1805_CR7","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1158\/1078-0432.CCR-13-2675","volume":"20","author":"W Mydlarz","year":"2014","unstructured":"Mydlarz W, Uemura M, Ahn S, Hennessey P, Chang S, Demokan S, et al. Clusterin is a gene-specific target of microRNA-21 in head and neck squamous cell carcinoma. Clin Cancer Res. 2014;20:868\u201377. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2675.","journal-title":"Clin Cancer Res"},{"key":"1805_CR8","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/sj.bjc.6601373","volume":"89","author":"F Lemaire","year":"2003","unstructured":"Lemaire F, Millon R, Young J, Cromer A, Wasylyk C, Schultz I, et al. Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br J Cancer. 2003;89:1940\u20139. https:\/\/doi.org\/10.1038\/sj.bjc.6601373.","journal-title":"Br J Cancer"},{"key":"1805_CR9","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41467-023-36625-z","volume":"14","author":"JH Choi","year":"2023","unstructured":"Choi JH, Lee BS, Jang JY, Lee YS, Kim HJ, Roh J, et al. Single-cell transcriptome profiling of the stepwise progression of head and neck cancer. Nat Commun. 2023;14:1082. https:\/\/doi.org\/10.1038\/s41467-023-36625-z.","journal-title":"Nat Commun"},{"key":"1805_CR10","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.bbagrm.2014.10.004","volume":"1849","author":"M Bonacini","year":"2015","unstructured":"Bonacini M, Coletta M, Ramazzina I, Naponelli V, Modernelli A, Davalli P, et al. Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells. Biochim Biophys Acta Gene Regul Mech. 2015;1849:1244\u201353. https:\/\/doi.org\/10.1016\/j.bbagrm.2014.10.004.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"1805_CR11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41568-022-00455-2","volume":"22","author":"DR Mani","year":"2022","unstructured":"Mani DR, Krug K, Zhang B, Satpathy S, Clauser KR, Ding L, et al. Cancer proteogenomics: Current impact and future prospects. Nat Rev Cancer. 2022;22:647\u201364. https:\/\/doi.org\/10.1038\/s41568-022-00455-2.","journal-title":"Nat Rev Cancer"},{"key":"1805_CR12","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.3390\/cancers14122729","volume":"14","author":"S Cabezas-Camarero","year":"2022","unstructured":"Cabezas-Camarero S, Su\u00e1rez C, S\u00e1nchez-Canteli M, et al. Liquid biopsy in head and neck cancer: Current evidence and future perspectives. Cancers. 2022;14:2729. https:\/\/doi.org\/10.3390\/cancers14122729.","journal-title":"Cancers"},{"key":"1805_CR13","doi-asserted-by":"publisher","first-page":"pkz055","DOI":"10.1093\/jncics\/pkz055","volume":"3","author":"P Gougis","year":"2019","unstructured":"Gougis P, Moreau Bachelard C, Kamal M, Gan HK, Borcoman E, Torossian N, et al. Clinical development of molecular targeted therapy in head and neck squamous cell carcinoma. JNCI Cancer Spectr. 2019;3:pkz055. https:\/\/doi.org\/10.1093\/jncics\/pkz055.","journal-title":"JNCI Cancer Spectr"},{"key":"1805_CR14","doi-asserted-by":"publisher","first-page":"7657876","DOI":"10.1155\/2022\/7657876","volume":"2022","author":"E Janiszewska","year":"2022","unstructured":"Janiszewska E, Kmieciak A, Kacperczyk M, Witkowska A, Kratz EM. The influence of clusterin glycosylation variability on selected pathophysiological processes in the human body. Oxid Med Cell Longev. 2022;2022:7657876. https:\/\/doi.org\/10.1155\/2022\/7657876.","journal-title":"Oxid Med Cell Longev"},{"key":"1805_CR15","doi-asserted-by":"publisher","first-page":"a013359","DOI":"10.1101\/cshperspect.a013359","volume":"5","author":"J Breitling","year":"2013","unstructured":"Breitling J, Aebi M. N-linked protein glycosylation in the endoplasmic reticulum. Cold Spring Harb Perspect Biol. 2013;5:a013359. https:\/\/doi.org\/10.1101\/cshperspect.a013359.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1805_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.oor.2024.100690","volume":"12","author":"J Nandhini","year":"2024","unstructured":"Nandhini J, Karthikeyan E. Crosstalk between cancer-associated fibroblasts (CAF) and tumour cells in head and neck cancer-unraveling the complex pathway and CAF-targeted therapy. Oral Oncol Rep. 2024;12:100690. https:\/\/doi.org\/10.1016\/j.oor.2024.100690.","journal-title":"Oral Oncol Rep"},{"key":"1805_CR17","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.48255","volume":"8","author":"SK Herring","year":"2019","unstructured":"Herring SK, Moon HJ, Rawal P, Chhibber A, Zhao L. Brain clusterin protein isoforms and mitochondrial localization. eLife. 2019;8:e48255. https:\/\/doi.org\/10.7554\/eLife.48255.","journal-title":"eLife"},{"key":"1805_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00164","volume":"13","author":"EM Foster","year":"2019","unstructured":"Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ. Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci. 2019;13:164. https:\/\/doi.org\/10.3389\/fnins.2019.00164.","journal-title":"Front Neurosci"},{"key":"1805_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1167886","volume":"15","author":"G Milinkeviciute","year":"2023","unstructured":"Milinkeviciute G, Green KN. Clusterin\/apolipoprotein J, its isoforms and Alzheimer\u2019s disease. Front Aging Neurosci. 2023;15:1167886. https:\/\/doi.org\/10.3389\/fnagi.2023.1167886.","journal-title":"Front Aging Neurosci"},{"key":"1805_CR20","doi-asserted-by":"publisher","DOI":"10.4172\/2168-9857.1000134","volume":"3","author":"Q Guan","year":"2014","unstructured":"Guan Q, Alnasser HA, Nguan CYC, Du C. From humans to experimental models: the cytoprotective role of clusterin in the kidney. Med Surg Urol. 2014;3:1000134. https:\/\/doi.org\/10.4172\/2168-9857.1000134.","journal-title":"Med Surg Urol"},{"key":"1805_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/1073274821103843","volume":"29","author":"A Beheshti Namdar","year":"2022","unstructured":"Beheshti Namdar A, Kabiri M, Mosanan Mozaffari H, Aminifar E, Mehrad-Majd H. Circulating clusterin levels and cancer risk: a systematic review and meta-analysis. Cancer Control. 2022;29:1073274821103843. https:\/\/doi.org\/10.1177\/1073274821103843.","journal-title":"Cancer Control"},{"key":"1805_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/pros.10054","volume":"50","author":"LV July","year":"2002","unstructured":"July LV, Akbari M, Zellweger T, Jones EC, Goldenberg SL, Gleave ME. Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy. Prostate. 2002;50:219\u201327. https:\/\/doi.org\/10.1002\/pros.10054.","journal-title":"Prostate"},{"key":"1805_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/21655979.2020.1867768","volume":"12","author":"QF Chen","year":"2021","unstructured":"Chen QF, Chang L, Su Q, Zhao Y, Kong B. Clinical importance of serum secreted clusterin in predicting invasive breast cancer and treatment responses. Bioengineered. 2021;12:299\u2013309. https:\/\/doi.org\/10.1080\/21655979.2020.1867768.","journal-title":"Bioengineered"},{"key":"1805_CR24","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.21037\/tlcr-20-1298","volume":"10","author":"J Tan","year":"2021","unstructured":"Tan J, Guo W, Yang S, Han D, Li H. The multiple roles and therapeutic potential of clusterin in non-small-cell lung cancer: a narrative review. Transl Lung Cancer Res. 2021;10:1980\u201393. https:\/\/doi.org\/10.21037\/tlcr-20-1298.","journal-title":"Transl Lung Cancer Res"},{"key":"1805_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10555-024-10157-7","volume":"43","author":"S Hlavca","year":"2024","unstructured":"Hlavca S, Chan WH, Engel RM, Abud HE. Clusterin: a marker and mediator of chemoresistance in colorectal cancer. Cancer Metastasis Rev. 2024;43:1\u201314. https:\/\/doi.org\/10.1007\/s10555-024-10157-7.","journal-title":"Cancer Metastasis Rev"},{"key":"1805_CR26","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s00018-010-0256-4","volume":"67","author":"F Rizzi","year":"2010","unstructured":"Rizzi F, Bettuzzi S. The clusterin paradigm in prostate and other cancers: regulatory roles for clusterin in apoptosis, proliferation and tumorigenesis. Cell Mol Life Sci. 2010;67:1627\u201339. https:\/\/doi.org\/10.1007\/s00018-010-0256-4.","journal-title":"Cell Mol Life Sci"},{"key":"1805_CR27","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1074\/mcp.M700026-MCP200","volume":"6","author":"CL Andersen","year":"2007","unstructured":"Andersen CL, Schepeler T, Thorsen K, Birkenkamp-Demtr\u00f6der K, Mansilla F, Aaltonen LA, et al. Clusterin expression in normal mucosa and colorectal cancer. Mol Cell Proteom. 2007;6:1039\u201348. https:\/\/doi.org\/10.1074\/mcp.M700026-MCP200.","journal-title":"Mol Cell Proteom"},{"key":"1805_CR28","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1038\/sj.onc.1207469","volume":"23","author":"S Pucci","year":"2004","unstructured":"Pucci S, Bonanno E, Pichiorri F, Angeloni C, Spagnoli LG. Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene. 2004;23:2298\u2013304. https:\/\/doi.org\/10.1038\/sj.onc.1207469.","journal-title":"Oncogene"},{"key":"1805_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1042\/BJ20051353","volume":"395","author":"F Loison","year":"2006","unstructured":"Loison F, Debure L, Nizard P, Le Goff P, Michel D, Le Dr\u00e9an Y. Up-regulation of the clusterin gene after proteotoxic stress: implication of HSF1\u2013HSF2 heterocomplexes. Biochem J. 2006;395:223\u201331. https:\/\/doi.org\/10.1042\/BJ20051353.","journal-title":"Biochem J"},{"key":"1805_CR30","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1074\/jbc.M610619200","volume":"282","author":"DR Cochrane","year":"2007","unstructured":"Cochrane DR, Wang Z, Muramaki M, Gleave ME, Nelson CC. Differential regulation of clusterin and its isoforms by androgens in prostate cells. J Biol Chem. 2007;282:2278\u201387. https:\/\/doi.org\/10.1074\/jbc.M610619200.","journal-title":"J Biol Chem"},{"key":"1805_CR31","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1158\/1078-0432.CCR-15-0866","volume":"21","author":"Y Yamamoto","year":"2015","unstructured":"Yamamoto Y, Lin PJ, Beraldi E, Zhang F, Kawai Y, Leong J, et al. SiRNA lipid nanoparticle potently silences clusterin and delays progression when combined with androgen receptor cotargeting in enzalutamide-resistant prostate cancer. Clin Cancer Res. 2015;21:4845\u201355. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0866.","journal-title":"Clin Cancer Res"},{"key":"1805_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1158\/1078-0432.CCR-08-1805","volume":"15","author":"IP Trougakos","year":"2009","unstructured":"Trougakos IP, Lourda M, Antonelou MH, Kletsas D, Gorgoulis VG, Papassideri IS, et al. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex. Clin Cancer Res. 2009;15:48\u201359. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-1805.","journal-title":"Clin Cancer Res"},{"key":"1805_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/0008-5472.CAN-08-2912","volume":"69","author":"IP Trougakos","year":"2009","unstructured":"Trougakos IP, Djeu JY, Gonos ES, Boothman DA. Advances and challenges in basic and translational research on clusterin. Cancer Res. 2009;69:403\u20136. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2912.","journal-title":"Cancer Res"},{"key":"1805_CR34","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2012.1082","author":"X Ma","year":"2012","unstructured":"Ma X, Bai Y. Detection of significant pathways in osteoporosis based on graph clustering. Mol Med Rep. 2012. https:\/\/doi.org\/10.3892\/mmr.2012.1082.","journal-title":"Mol Med Rep"},{"issue":"1","key":"1805_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000351923","volume":"93","author":"X Wang","year":"2014","unstructured":"Wang X, Luo L, Dong D, Yu Q, Zhao K. Clusterin plays an important role in clear renal cell cancer metastasis. Urol Int. 2014;93(1):53. https:\/\/doi.org\/10.1159\/000351923.","journal-title":"Urol Int"},{"key":"1805_CR36","doi-asserted-by":"publisher","unstructured":"Fu Y, Lai Y, Wang Q, Liu X, He W, Zhang H, et al. Overexpression of clusterin promotes angiogenesis via the vascular endothelial growth factor in primary ovarian cancer. Mol Med Rep. 2013;1646. https:\/\/doi.org\/10.3892\/mmr.2013.1436.","DOI":"10.3892\/mmr.2013.1436"},{"key":"1805_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10238-022-00885-2","volume":"23","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Lv X, Chen L, Liu Y. The role and function of CLU in cancer biology and therapy. Clin Exp Med. 2023;23:439\u201349. https:\/\/doi.org\/10.1007\/s10238-022-00885-2.","journal-title":"Clin Exp Med"},{"key":"1805_CR38","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1074\/jbc.M209233200","volume":"278","author":"KS Leskov","year":"2003","unstructured":"Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem. 2003;278:11590\u2013600. https:\/\/doi.org\/10.1074\/jbc.M209233200.","journal-title":"J Biol Chem"},{"key":"1805_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/ijms.96274","volume":"21","author":"J Liao","year":"2024","unstructured":"Liao J, Chen R, Lin B, Deng R, Liang Y, Zeng J, et al. Cross-talk between the TGF-\u03b2 and cell adhesion signaling pathways in cancer. Int J Med Sci. 2024;21:1\u201314. https:\/\/doi.org\/10.7150\/ijms.96274.","journal-title":"Int J Med Sci"},{"key":"1805_CR40","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.2147\/CMAR.S196273","volume":"11","author":"M Peng","year":"2019","unstructured":"Peng M, Deng J, Zhou S, Tao T, Su Q, Yang X, et al. The role of clusterin in cancer metastasis. Cancer Manag Res. 2019;11:2405\u201314. https:\/\/doi.org\/10.2147\/CMAR.S196273.","journal-title":"Cancer Manag Res"},{"key":"1805_CR41","doi-asserted-by":"publisher","first-page":"26620","DOI":"10.1074\/jbc.272.42.26620","volume":"272","author":"G Jin","year":"1997","unstructured":"Jin G, Howe PH. Regulation of clusterin gene expression by transforming growth factor \u03b2. J Biol Chem. 1997;272:26620\u20136. https:\/\/doi.org\/10.1074\/jbc.272.42.26620.","journal-title":"J Biol Chem"},{"key":"1805_CR42","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.bbadis.2015.05.002","volume":"1852","author":"M Deb","year":"2015","unstructured":"Deb M, Sengupta D, Rath SK, Kar S, Parbin S, Shilpi A, et al. Dimerization propensities of Synucleins are not predictive for Synuclein aggregation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2015;1852:2642\u201354. https:\/\/doi.org\/10.1016\/j.bbadis.2015.05.002.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"1805_CR43","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1016\/j.ejca.2009.02.024","volume":"45","author":"T Liu","year":"2009","unstructured":"Liu T, Liu PY, Tee AE, Haber M, Norris MD, Gleave ME, et al. Health behaviours in older cancer survivors in the English Longitudinal Study of Ageing. Eur J Cancer. 2009;45:2406\u201314. https:\/\/doi.org\/10.1016\/j.ejca.2009.02.024.","journal-title":"Eur J Cancer"},{"key":"1805_CR44","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1074\/jbc.M111.252957","volume":"286","author":"KS Leskov","year":"2011","unstructured":"Leskov KS, Araki S, Lavik JP, Gomez JA, Gama V, Gonos ES, et al. CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor. J Biol Chem. 2011;286:4005\u201315. https:\/\/doi.org\/10.1074\/jbc.M111.252957.","journal-title":"J Biol Chem"},{"key":"1805_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13000-020-01027-0","volume":"15","author":"Y Li","year":"2020","unstructured":"Li Y, Liu F, Zhou W, Zhang S, Chu P, Lin F, et al. Diagnostic value of clusterin immunostaining in hepatocellular carcinoma. Diagn Pathol. 2020;15:127. https:\/\/doi.org\/10.1186\/s13000-020-01027-0.","journal-title":"Diagn Pathol"},{"key":"1805_CR46","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/bfgp\/elq028","volume":"9","author":"S Kishore","year":"2010","unstructured":"Kishore S, Luber S, Zavolan M. Deciphering the role of RNA-binding proteins in the post-transcriptional control of gene expression. Brief Funct Genomics. 2010;9:391\u2013404. https:\/\/doi.org\/10.1093\/bfgp\/elq028.","journal-title":"Brief Funct Genomics"},{"key":"1805_CR47","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.semcancer.2022.03.025","volume":"86","author":"W Li","year":"2022","unstructured":"Li W, Deng X, Chen J. RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer. Semin Cancer Biol. 2022;86:856\u201368. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.025.","journal-title":"Semin Cancer Biol"},{"key":"1805_CR48","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/S1357-2725(02)00090-2","volume":"34","author":"IP Trougakos","year":"2002","unstructured":"Trougakos IP, Gonos ES. Clusterin\/apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol. 2002;34:1430\u201348. https:\/\/doi.org\/10.1016\/S1357-2725(02)00090-2.","journal-title":"Int J Biochem Cell Biol"},{"key":"1805_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105563","volume":"121","author":"S Das","year":"2021","unstructured":"Das S, Bhattacharya S, Roy S. Diagnostic value of indocyanine green for sentinel lymph node mapping and lymph node metastasis in oral\/oropharyngeal carcinoma. Oral Oncol. 2021;121:105563. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105563.","journal-title":"Oral Oncol"},{"key":"1805_CR50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/CAD.0000000000000515","volume":"28","author":"M Garc\u00eda-Aranda","year":"2017","unstructured":"Garc\u00eda-Aranda M, T\u00e9llez T, Mu\u00f1oz M, Redondo M. Complete response to anti-PD-1 nivolumab in massive skin metastasis from melanoma. Anti-Cancer Drugs. 2017;28:85\u201398. https:\/\/doi.org\/10.1097\/CAD.0000000000000515.","journal-title":"Anti-Cancer Drugs"},{"key":"1805_CR51","doi-asserted-by":"publisher","unstructured":"Wadsworth JT, Somers KD, Stack BC Jr, Cazares L, Malik G, Adam BL, et al. Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg. 2004;130:98\u2013104. https:\/\/doi.org\/10.1001\/archotol.130.1.98.","DOI":"10.1001\/archotol.130.1.98"},{"key":"1805_CR52","doi-asserted-by":"publisher","first-page":"776","DOI":"10.4103\/jcrt.JCRT85718","volume":"16","author":"D Kasradze","year":"2020","unstructured":"Kasradze D, Juodzbalys G, Guobis Z, Gervickas A, Cicci\u00f9 M. Genetic and proteomic biomarkers of head-and-neck cancer: a systematic review. J Cancer Res Ther. 2020;16:776\u201383. https:\/\/doi.org\/10.4103\/jcrt.JCRT85718.","journal-title":"J Cancer Res Ther"},{"key":"1805_CR53","doi-asserted-by":"publisher","first-page":"6246","DOI":"10.1158\/1078-0432.CCR-07-5037","volume":"14","author":"S Hu","year":"2008","unstructured":"Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res. 2008;14:6246\u201352. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-5037.","journal-title":"Clin Cancer Res"},{"key":"1805_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/17246008221132928","volume":"37","author":"G Gao","year":"2022","unstructured":"Gao G, Luan X. Diagnostic performance of clusterin in hepatocellular carcinoma: a meta-analysis. Int J Biol Markers. 2022;37:83\u20139. https:\/\/doi.org\/10.1177\/17246008221132928.","journal-title":"Int J Biol Markers"},{"key":"1805_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/168960","volume":"2014","author":"W Guo","year":"2014","unstructured":"Guo W, Ma X, Xue C, Luo J, Zhu X, Xiang J, et al. Serum clusterin as a tumor marker and prognostic factor for patients with esophageal cancer. Dis Markers. 2014;2014:1. https:\/\/doi.org\/10.1155\/2014\/168960.","journal-title":"Dis Markers"},{"key":"1805_CR56","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1158\/1055-9965.EPI-08-0302","volume":"18","author":"D Kevans","year":"2009","unstructured":"Kevans D, Foley J, Tenniswood M, Sheahan K, Hyland J, O\u2019Donoghue D, et al. High clusterin expression correlates with a poor outcome in stage II colorectal cancers. Cancer Epidemiol Biomarkers Prev. 2009;18:393\u20139. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0302.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1805_CR57","doi-asserted-by":"publisher","first-page":"1056184","DOI":"10.3389\/fgene.2022.1056184","volume":"14","author":"Y Fu","year":"2023","unstructured":"Fu Y, Du Q, Cui T, Lu Y, Niu G. A pan-cancer analysis reveals role of clusterin (CLU) in carcinogenesis and prognosis of human tumors. Front Genet. 2023;14:1056184. https:\/\/doi.org\/10.3389\/fgene.2022.1056184.","journal-title":"Front Genet"},{"key":"1805_CR58","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1515\/biol-2025-1082","volume":"20","author":"J Zhou","year":"2025","unstructured":"Zhou J, Lu X, Xie Y, Mao G. Clusterin activates the heat shock response via the PI3K\/Akt pathway to protect cardiomyocytes from high-temperature-induced apoptosis. Open Life Sci. 2025;20:202\u201312. https:\/\/doi.org\/10.1515\/biol-2025-1082.","journal-title":"Open Life Sci"},{"key":"1805_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jons.2020.06.001","volume":"6","author":"LA Muhammad","year":"2020","unstructured":"Muhammad LA, Saad F. The role of clusterin in head and neck squamous cell carcinoma progression: involvement of miRNA-21 and p53 pathways. J Oncol Sci. 2020;6:105\u201311. https:\/\/doi.org\/10.1016\/j.jons.2020.06.001.","journal-title":"J Oncol Sci"},{"key":"1805_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15020769","volume":"15","author":"A Michcik","year":"2026","unstructured":"Michcik A, Wojciechowska B, Tarnawski J, Choma P, Polcyn A, Garbacewicz \u0141, et al. Diagnostic, prognostic, and predictive molecular biomarkers in head and neck squamous cell carcinoma: a comprehensive review. J Clin Med. 2026;15:769. https:\/\/doi.org\/10.3390\/jcm15020769.","journal-title":"J Clin Med"},{"key":"1805_CR61","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1200\/JCO.2013.54.5228","volume":"32","author":"CH Chung","year":"2014","unstructured":"Chung CH, Zhang Q, Kong CS, Harris J, Fertig EJ, Harari PM, et al. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma. J Clin Oncol. 2014;32:3930\u20138. https:\/\/doi.org\/10.1200\/JCO.2013.54.5228.","journal-title":"J Clin Oncol"},{"key":"1805_CR62","first-page":"209","volume":"10","author":"G Jaiswal","year":"2013","unstructured":"Jaiswal G, Jaiswal S, Kumar R, Sharma A. Field cancerization: concept and clinical implications in head and neck squamous cell carcinoma. J Exp Ther Oncol. 2013;10:209\u201314.","journal-title":"J Exp Ther Oncol"},{"key":"1805_CR63","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1600-0463.2010.02606.x","volume":"118","author":"CB Lajer","year":"2010","unstructured":"Lajer CB, Buchwald CV. The role of human papillomavirus in head and neck cancer. APMIS. 2010;118:510\u20139. https:\/\/doi.org\/10.1111\/j.1600-0463.2010.02606.x.","journal-title":"APMIS"},{"key":"1805_CR64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.55133\/eji.290204","volume":"29","author":"HS Rasmy","year":"2022","unstructured":"Rasmy HS, Mohammed HA, Mohammed ES, Ahmed AS, Isaac A. Serum clusterin as a promising diagnostic and prognostic marker for hepatocellular carcinoma after locoregional treatment. Egypt J Immunol. 2022;29:26\u201340.","journal-title":"Egypt J Immunol"},{"key":"1805_CR65","doi-asserted-by":"publisher","first-page":"219","DOI":"10.37047\/jos.galenos.2025.2025-8-3","volume":"11","author":"B Yildiz","year":"2025","unstructured":"Yildiz B, \u015eahin TK, G\u00fcven DC, Aksoy S. The prognostic value of EGFR amplifications in head and neck squamous cell carcinoma. J Oncol Sci. 2025;11:219\u201325. https:\/\/doi.org\/10.37047\/jos.galenos.2025.2025-8-3.","journal-title":"J Oncol Sci"},{"key":"1805_CR66","doi-asserted-by":"publisher","unstructured":"Hsieh JCH, Wang HM, Wu MH, Chang KP, Chang PH, Liao CT, et al. Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma. Head Neck. 2019;3045. https:\/\/doi.org\/10.1002\/hed.25437.","DOI":"10.1002\/hed.25437"},{"key":"1805_CR67","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1109\/JBHI.2015.2489158","volume":"21","author":"CD Kaddi","year":"2015","unstructured":"Kaddi CD, Wang MD. Models for predicting stage in head and neck squamous cell carcinoma using proteomic and transcriptomic data. IEEE J Biomed Health Inf. 2015;21:246\u201353. https:\/\/doi.org\/10.1109\/JBHI.2015.2489158.","journal-title":"IEEE J Biomed Health Inf"},{"key":"1805_CR68","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1158\/0008-5472.CAN-23-3125","volume":"84","author":"P Diao","year":"2024","unstructured":"Diao P, Dai Y, Wang A, Bu X, Wang Z, Li J, et al. Integrative multiomics analyses identify molecular subtypes of head and neck squamous cell carcinoma with distinct therapeutic vulnerabilities. Cancer Res. 2024;84:2283\u201398. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-3125.","journal-title":"Cancer Res"},{"key":"1805_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.713561","volume":"11","author":"J Mitsuda","year":"2021","unstructured":"Mitsuda J, Tsujikawa T, Yoshimura K, Saburi S, Suetsugu M, Kitamoto K, et al. A 14-marker multiplexed imaging panel for prognostic biomarkers and tumor heterogeneity in head and neck squamous cell carcinoma. Front Oncol. 2021;11:713561. https:\/\/doi.org\/10.3389\/fonc.2021.713561.","journal-title":"Front Oncol"},{"key":"1805_CR70","doi-asserted-by":"crossref","unstructured":"Chi KN. A Phase I\/II study of combination neoadjuvant hormone therapy and weekly OGX-011 prior to radical prostatectomy in patients with localized prostate cancer (NCT00054106). ClinicalTrials.gov. 2006. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00054106","DOI":"10.21236\/ADA473775"},{"key":"1805_CR71","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/jnci\/dji256","volume":"97","author":"KN Chi","year":"2005","unstructured":"Chi KN, Eisenhauer E, Fazli L, Jones EC, Goldenberg SL, Powers J, et al. A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2\u2032-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer. J Natl Cancer Inst. 2005;97:1287\u201396. https:\/\/doi.org\/10.1093\/jnci\/dji256.","journal-title":"J Natl Cancer Inst"},{"key":"1805_CR72","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.1158\/1078-0432.CCR-11-0859","volume":"17","author":"F Saad","year":"2011","unstructured":"Saad F, Hotte S, North S, Eigl B, Chi K, Czaykowski P, et al. Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c. Clin Cancer Res. 2011;17:5760\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0859.","journal-title":"Clin Cancer Res"},{"key":"1805_CR73","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1158\/1078-0432.CCR-08-1159","volume":"15","author":"S Chia","year":"2009","unstructured":"Chia S, Dent S, Ellard S, Ellis PM, Vandenberg T, Gelmon K, et al. Phase II trial of OGX 011 in combination with docetaxel in metastatic breast cancer. Clin Cancer Res. 2009;15:708\u201313. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-1159.","journal-title":"Clin Cancer Res"},{"key":"1805_CR74","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S1470-2045(17)30169-7","volume":"18","author":"KN Chi","year":"2017","unstructured":"Chi KN, Higano CS, Blumenstein B, Ferrero JM, Reeves J, Feyerabend S, et al. Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): A phase 3, multicentre, open-label, randomised trial. Lancet Oncol. 2017;18:473\u201385. https:\/\/doi.org\/10.1016\/S1470-2045(17)30169-7.","journal-title":"Lancet Oncol"},{"key":"1805_CR75","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/JTO.0b013e31823f459c","volume":"7","author":"JJ Laskin","year":"2012","unstructured":"Laskin JJ, Nicholas G, Lee C, Gitlitz B, Vincent M, Cormier Y, et al. Phase I\/II trial of custirsen (OGX 011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non small cell lung cancer. J Thorac Oncol. 2012;7:579\u201386. https:\/\/doi.org\/10.1097\/JTO.0b013e31823f459c.","journal-title":"J Thorac Oncol"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01805-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-026-01805-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01805-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T09:37:08Z","timestamp":1781861828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-026-01805-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1805"],"URL":"https:\/\/doi.org\/10.1007\/s11912-026-01805-3","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\u00a0<!--Emphasis Type='Bold' removed-->and informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}